Elderly subgroup analysis of a randomized phase 3 trial of gemcitabine (G) in combination with carboplatin (Cb) or paclitaxel (P) compared to paclitaxel plus carboplatin in advanced (stage IIIB, IV) non-small cell lung cancer (NSCLC)

Rafat Ansari,René Gonin,M. A. Socinski,Martin J. Edelman,Robert B. Catalano,Donna M. Marinucci,Robert L. Comis,Coleman K. Obasaju,Joseph Treat,Chandra P. Belani

Elderly subgroup analysis of a randomized phase 3 trial of gemcitabine (G) in combination with carboplatin (Cb) or paclitaxel (P) compared to paclitaxel plus carboplatin in advanced (stage IIIB, IV) non-small cell lung cancer (NSCLC)

2016

Rafat Ansari
René Gonin
M. A. Socinski
Martin J. Edelman
Robert B. Catalano
Donna M. Marinucci
Robert L. Comis
Coleman K. Obasaju
Joseph Treat
Chandra P. Belani

7665 Background: Efficacy and safety of platinum-based chemotherapy doublets in elderly (ELD) NSCLC pts with good PS have been reported to be similar to those in younger pts (N-ELD). However, littl...

Keywords:

non-small cell lung cancer (NSCLC)
Subgroup analysis
Pathology
Oncology
Gemcitabine
Paclitaxel
Carboplatin
Medicine
Internal medicine
Chemotherapy
advanced stage

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations